L.B.J. van Iersel

460 total citations
7 papers, 152 citations indexed

About

L.B.J. van Iersel is a scholar working on Hepatology, Oncology and Hematology. According to data from OpenAlex, L.B.J. van Iersel has authored 7 papers receiving a total of 152 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hepatology, 4 papers in Oncology and 2 papers in Hematology. Recurrent topics in L.B.J. van Iersel's work include Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Colorectal Cancer Treatments and Studies (2 papers) and Multiple Myeloma Research and Treatments (2 papers). L.B.J. van Iersel is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Colorectal Cancer Treatments and Studies (2 papers) and Multiple Myeloma Research and Treatments (2 papers). L.B.J. van Iersel collaborates with scholars based in Netherlands. L.B.J. van Iersel's co-authors include Peter J.K. Kuppen, Alexander L. Vahrmeijer, Hans Gelderblom, Fred G. J. Tijl, Cornelis J.�H. van de Velde, J.W.R. Nortier, Rob A.�E.�M. Tollenaar, H.H. Hartgrink, Robert A.E.M. Tollenaar and C.J.H. van de Velde and has published in prestigious journals such as Annals of Oncology, Annals of Surgical Oncology and Journal of Surgical Research.

In The Last Decade

L.B.J. van Iersel

7 papers receiving 147 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L.B.J. van Iersel Netherlands 7 71 63 58 27 23 7 152
J. Bauer Germany 3 20 0.3× 105 1.7× 91 1.6× 18 0.7× 44 1.9× 5 165
Lynn J. Poole Perry United States 7 31 0.4× 106 1.7× 42 0.7× 52 1.9× 58 2.5× 11 255
Nicholas Coupe United Kingdom 7 6 0.1× 8 0.1× 139 2.4× 24 0.9× 72 3.1× 19 220
Elena Simón Polo Spain 4 7 0.1× 31 0.5× 225 3.9× 7 0.3× 31 1.3× 8 310
Sandrine Payrard France 6 32 0.5× 6 0.1× 246 4.2× 3 0.1× 29 1.3× 6 304
Lucie Heinzerling Germany 8 4 0.1× 10 0.2× 146 2.5× 6 0.2× 70 3.0× 22 210
Muhammad Adnan Khattak Australia 9 2 0.0× 42 0.7× 185 3.2× 23 0.9× 77 3.3× 33 264
Ornella J. Rullo United States 5 7 0.1× 2 0.0× 28 0.5× 20 0.7× 42 1.8× 6 237
Zhiqiang Gao China 6 11 0.2× 4 0.1× 192 3.3× 44 1.6× 55 2.4× 19 298
Gentry Teng King United States 6 8 0.1× 2 0.0× 108 1.9× 38 1.4× 46 2.0× 23 197

Countries citing papers authored by L.B.J. van Iersel

Since Specialization
Citations

This map shows the geographic impact of L.B.J. van Iersel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L.B.J. van Iersel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L.B.J. van Iersel more than expected).

Fields of papers citing papers by L.B.J. van Iersel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L.B.J. van Iersel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L.B.J. van Iersel. The network helps show where L.B.J. van Iersel may publish in the future.

Co-authorship network of co-authors of L.B.J. van Iersel

This figure shows the co-authorship network connecting the top 25 collaborators of L.B.J. van Iersel. A scholar is included among the top collaborators of L.B.J. van Iersel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L.B.J. van Iersel. L.B.J. van Iersel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Iersel, L.B.J. van, Emily Leede, Alexander L. Vahrmeijer, et al.. (2014). Isolated hepatic perfusion with oxaliplatin combined with 100 mg melphalan in patients with metastases confined to the liver: A phase I study. European Journal of Surgical Oncology. 40(11). 1557–1563. 13 indexed citations
2.
Iersel, L.B.J. van, Miriam Koopman, Cornelis J.�H. van de Velde, et al.. (2010). Management of isolated nonresectable liver metastases in colorectal cancer patients: a case–control study of isolated hepatic perfusion with melphalan versus systemic chemotherapy. Annals of Oncology. 21(8). 1662–1667. 17 indexed citations
3.
Iersel, L.B.J. van, Alexander L. Vahrmeijer, J.W.R. Nortier, et al.. (2009). In Vitro Schedule-Dependent Interaction Between Melphalan and Oxaliplatin in Human Colorectal Cancer Cell Lines. Journal of Surgical Research. 167(2). 273–278. 12 indexed citations
4.
Iersel, L.B.J. van, Hans Gelderblom, Alexander L. Vahrmeijer, et al.. (2008). Isolated hepatic melphalan perfusion of colorectal liver metastases: outcome and prognostic factors in 154 patients. Annals of Oncology. 19(6). 1127–1134. 38 indexed citations
5.
Iersel, L.B.J. van, Hans Gelderblom, Alexander L. Vahrmeijer, et al.. (2008). Isolated Hepatic Perfusion with 200 mg Melphalan for Advanced Noncolorectal Liver Metastases. Annals of Surgical Oncology. 15(7). 1891–8. 38 indexed citations
6.
Iersel, L.B.J. van, Alexander L. Vahrmeijer, Fred G. J. Tijl, et al.. (2007). Hepatic artery infusion of high-dose melphalan at reduced flow during isolated hepatic perfusion for the treatment of colorectal metastases confined to the liver: A clinical and pharmacologic evaluation. European Journal of Surgical Oncology. 33(7). 874–881. 19 indexed citations
7.
Vlierberghe, Ronald L. P. van, Maro H. Sandel, Frans A. Prins, et al.. (2005). Four‐color staining combining fluorescence and brightfield microscopy for simultaneous immune cell phenotyping and localization in tumor tissue sections. Microscopy Research and Technique. 67(1). 15–21. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026